ArticleWorld journal of gastroenterology2016

Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B.

Hong-Juan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.